| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Michael Celano is Chief Financial Officer at LRMR, with reported holdings spanning 2 companies. Michael Celano's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $943K at current prices.
Our model assigns Michael Celano a strong insider score of 72/100, based on 3 past trades. Over a 12-month horizon, all 3 of those trades were profitable, with an average 12-month return of +58.6%.
Michael Celano's largest disclosed position is in LRMR as Chief Financial Officer, worth about $548K. Net of sales, the LRMR filings show accumulation of 36,746 shares.
Michael Celano has 27 Form 4 filings on record from May 2015 to January 2026, across 2 companies: Chief Financial Officer at Larimar Therapeutics (LRMR), 2020–2026; Director at Orasure Technologies (OSUR), 2015–2022.
The 38 reported transactions were 12 stock awards, 10 option or other derivative awards, 7 tax withholdings and 4 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $173K and 4 sales worth about $1.1M.
The largest open-market purchase was 31,746 shares of LRMR at an average $3.15 on September 16, 2022, about $100K. Twelve months later LRMR was up 33%.
The largest open-market sale was 44,962 shares of OSUR at an average $14.95 on May 5, 2017, about $672K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | LRMR Larimar Therapeutics, Inc. | Chief Financial Officer | Buy | 5,000 | $3.73 | $18,631.50 | +4.6% | +13.3% | +101.4% | |
| Sep 16, 2022 | LRMR Larimar Therapeutics, Inc. | Chief Financial Officer | Buy | 31,746 | $3.15 | $99,999.90 | New | +42.5% | +32.5% | |
| Aug 12, 2022 | OSUR Orasure Technologies Inc | Director | Buy | 12,000 | $4.49 | $53,916.00 | +12.0% | +6.8% | +43.2% | |
| May 5, 2017 | OSUR Orasure Technologies Inc | Director | Sell | 44,962 | $14.95 | $672,181.90 | -54.1% | - | - | |
| Mar 2, 2017 | OSUR Orasure Technologies Inc | Director | Sale+OE | 15,000 | $12.00 | $180,000.00 | -15.3% | - | - | |
| Feb 9, 2017 | OSUR Orasure Technologies Inc | Director | Sell | 10,000 | $10.06 | $100,600.00 | -10.7% | - | - | |
| Jan 31, 2017 | OSUR Orasure Technologies Inc | Director | Sale+OE | 15,000 | $8.78 | $131,700.00 | -13.9% | - | - |